MYND Lifesciences Inc.
CSE: MYND
Company Overview
MYND Life Science Inc. is a leading life sciences company focussed on improving mental health. The company has confirmed access to Health Canada psilocybin research and development. Patents have been filed based on therapeutic approaches to treat diseases of the Central Nervous System using neuroactive agents including psychedelics and other compounds. Research and development is currently underway.
Financial Highlights
-$45,938
Revenue (ttm)
$0
Gross Profit (ttm)
-$0.10
Diluted EPS (ttm)
Management Team
Dr. Wilfred A. Jefferies
Co-Founder, Chairman & Chief Science Officer
Dr. Lyle Oberg M.D.
Co-Founder, CEO & Director
Mr. Lih-Ming Tam
Interim CFO & Sr. Controller
Dr. Chaahat S.B Singh
Sr. Operations & Research Mang.
Mr. Luke Warkentin
VP of Corp. Devel.
Dr. Iryna Saranchova Ph.D.
Chief Clinical Officer
Key Highlights
Market Capitalization
$0
Shares Outstanding
0
Shares Short (% of Float)
()
Insider Ownership
31%